ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,564.41
      1.08%
      US Tech 100
      19,304.80
      0.00%
      Dow Jones
      40,421.36
      0.33%
      Brent Oil
      81.615
      0.12%
      Bitcoin
      66,555.75
      -1.55%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. SAB Biotherapeutics Inc (SABS)

      7. SAB Biotherapeutics Inc (SABS) Financials

      SAB Biotherapeutics Inc

      SAB Biotherapeutics Inc (SABS)

      NASDAQ
      2.845
      0.00
      (0.00%)
      Closed July 23 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      SAB Biotherapeutics Inc Financial Summary

      The current SABS market cap is 26.26M. The company's latest EPS is USD -4.5718 and P/E is -0.61.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 581k86k1.27M305k945k
      Operating Income -7.4M-6.48M-5.32M-18.87M-11.39M
      Net Income -7.35M-6.88M-5.1M-22.86M-5.03M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 060.88M23.9M2.24M
      Operating Income -9k-13.39M-28.92M-38.08M
      Net Income -9k-17.15M-18.74M-42.19M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 42.67M35.44M28.34M83.94M71.37M
      Total Liabilities 18.27M15.73M13.08M26.64M18.55M
      Total Equity 24.4M19.72M15.26M57.3M52.82M
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 322k79.37M50.91M83.94M
      Total Liabilities 306k40.82M19.85M26.64M
      Total Equity 16k38.55M31.06M57.3M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)
      Operating -1.61M-6.51M-11.67M-25.12M-10.75M
      Investing -21k-44k-85k-153k-31.36M
      Financing -360k-724k-864k66.77M-394k
      Year End December 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Operating -10k3.76M-23.46M-25.12M
      Investing N/A -10.94M-2.09M-153k
      Financing 95k34.12M1.05M66.77M

      Stats and Ratios

      Market Cap 26.26M
      Price to Earnings Ratio -0.61
      Price to Sales Ratio 11.58
      Price to Cash Ratio 0.46
      Price to Book Ratio 0.45
      Dividend Yield -

      Share Statistics

      Shares Outstanding 9.23M
      Average Volume (1 week) 3.74k
      Average Volume (1 Month) 7.24k
      52 Week Change -66.53%
      52 Week High 10.50
      52 Week Low 2.36
      Spread (Intraday) 0.26 (8.5%)

      Company Info

      Company Name SAB Biotherapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.sab.bio
      Industry blank checks (6770)